FR2002160A1 - - Google Patents

Info

Publication number
FR2002160A1
FR2002160A1 FR6903863A FR6903863A FR2002160A1 FR 2002160 A1 FR2002160 A1 FR 2002160A1 FR 6903863 A FR6903863 A FR 6903863A FR 6903863 A FR6903863 A FR 6903863A FR 2002160 A1 FR2002160 A1 FR 2002160A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR6903863A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of FR2002160A1 publication Critical patent/FR2002160A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR6903863A 1968-02-19 1969-02-17 Withdrawn FR2002160A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US70664968A 1968-02-19 1968-02-19

Publications (1)

Publication Number Publication Date
FR2002160A1 true FR2002160A1 (fr) 1969-10-17

Family

ID=24838493

Family Applications (1)

Application Number Title Priority Date Filing Date
FR6903863A Withdrawn FR2002160A1 (fr) 1968-02-19 1969-02-17

Country Status (10)

Country Link
US (1) US3487155A (fr)
BE (1) BE728559A (fr)
CH (1) CH501608A (fr)
DE (1) DE1907330A1 (fr)
DK (1) DK123232B (fr)
FR (1) FR2002160A1 (fr)
GB (1) GB1256803A (fr)
IL (1) IL31639A0 (fr)
NL (1) NL6902423A (fr)
SE (1) SE350489B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1427141A (en) * 1972-05-03 1976-03-10 Bdh Pharmaceuticals Ltd 17-alka-1,3-diynyl- steroids
US5504074A (en) 1993-08-06 1996-04-02 Children's Medical Center Corporation Estrogenic compounds as anti-angiogenic agents
US6908910B2 (en) 1993-08-06 2005-06-21 The Children's Medical Center Corporation Estrogenic compounds as anti-mitotic agents
JP2002522477A (ja) 1998-08-11 2002-07-23 エントレメッド インコーポレイテッド 抗真菌薬としてのエストロゲン様化合物の使用
US7087592B1 (en) 1999-08-23 2006-08-08 Entre Med, Inc. Compositions comprising purified 2-methoxyestradiol and methods of producing same
US6995278B2 (en) 2000-08-18 2006-02-07 Entre Med, Inc. Antiangiogenic agents
US7135581B2 (en) 2000-08-18 2006-11-14 Entremed, Inc. Antiangiogenic agents

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE564226A (fr) *
FR1327004A (fr) * 1958-05-20 1963-05-17 British Drug Houses Ltd Procédé de fabrication de 17beta-hydroxy-17alpha-alkynyl-stéroïdes de l'androstane et du 3,5-cyclo-androstane

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE641351A (fr) * 1962-12-19
NL128376C (fr) * 1964-04-23

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE564226A (fr) *
FR1327004A (fr) * 1958-05-20 1963-05-17 British Drug Houses Ltd Procédé de fabrication de 17beta-hydroxy-17alpha-alkynyl-stéroïdes de l'androstane et du 3,5-cyclo-androstane

Also Published As

Publication number Publication date
DK123232B (da) 1972-05-29
DE1907330A1 (de) 1969-10-23
US3487155A (en) 1969-12-30
CH501608A (de) 1971-01-15
NL6902423A (fr) 1969-08-21
SE350489B (fr) 1972-10-30
BE728559A (fr) 1969-08-18
IL31639A0 (en) 1969-04-30
GB1256803A (fr) 1971-12-15

Similar Documents

Publication Publication Date Title
AU5506869A (fr)
AU5184069A (fr)
AU6168869A (fr)
FR2002160A1 (fr)
AU6171569A (fr)
AU2952567A (fr)
AU2581067A (fr)
AU4811568A (fr)
AU3224368A (fr)
AR203075Q (fr)
AU2580267A (fr)
AU2889368A (fr)
BE709119A (fr)
BE709496A (fr)
BE709484A (fr)
AU2496167A (fr)
BE723374A (fr)
BE709479A (fr)
BE709446A (fr)
BE709435A (fr)
BE725691A (fr)
BE709415A (fr)
BE709320A (fr)
AU4270368A (fr)
BE709319A (fr)

Legal Events

Date Code Title Description
ST Notification of lapse